Actively Recruiting
Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease
Led by Uskudar University · Updated on 2026-01-16
50
Participants Needed
1
Research Sites
11 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.
CONDITIONS
Official Title
Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male individuals aged 18-65 years
- Diagnosed with Peyronie's Disease stable for at least 6 months without increasing pain or curvature
- Presence of palpable penile plaque
You will not qualify if you...
- Acute inflammatory stage of Peyronie's disease with pain and progression
- Previous surgery, needle therapy, or extracorporeal shockwave therapy for Peyronie's disease
- Uncontrolled diabetes, severe coagulopathy, or current anticoagulant therapy
- History of penile cancer
- Severe erectile dysfunction
- Inability to comply with the study protocol or attend follow-up visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Koreya Serq Tebabeti
Baku, Azerbaijan
Actively Recruiting
Research Team
Ö
Ömer ŞEVGİN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here